直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Seminar

Evolving Patent Strategies: Recent PTAB Trends, AI Challenges, and Biotech Innovations

May 22, 2025

Tokyo, Japan

Finnegan

Register

Finnegan is pleased to announce that we will be hosting an in-person seminar in Tokyo on May 22, 2025. This seminar explores the forefront of patent strategy, providing the latest insights to help professionals navigate the rapidly evolving intellectual property landscape. Discussion will include the latest developments at the USPTO Trial and Appeal Board (PTAB), the impact of AI advancements and global networks on patent claiming practice, and optimized claiming strategies in biotechnology and pharmaceutical fields.

Topics will include:

  • Major Changes at the PTAB: New Discretionary Denial Procedures, PTAB Workload Measures, Evolving Strategy for Related Litigations 
  • Claiming Strategies in View of Network Exterritoriality and AI
  • Genus Claiming (including Means-Plus-Function Claiming) in the Biotechnology and Pharma Fields – Strategies in View of Post-Amgen Decisions

Presenters:
Erika Arner
Chiaki Kobayashi
Naoki Yoshida

Schedule: 
Registration: 13:15 - 13:30 
Seminar: 13:30 - 16:40 
Reception: 17:00 – 18:30 

Tags

Patent Trial and Appeal Board (PTAB), means-plus-function claim, AI + Patent

Related Practices

Appeals from the PTAB

Appeals, Issues, and Legal Strategy

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Prosecution and Portfolio Management

Appeals to the PTAB

Related Industries

AI, Electronics, and Information Technology

Artificial Intelligence (AI) and Machine Learning (ML)

Life Sciences

Pharmaceutical

Biotechnology

Related Offices

Reston, VA

Tokyo

Washington, DC

Related Professionals

Erika Harmon Arner
Partner
Washington, DC
+1 571 203 2754
Email
Chiaki Kobayashi
Partner
Tokyo
+ 813 3 431 6525
Email
Naoki Yoshida
Partner
Washington, DC
+1 202 408 6057
Email

Related Insights

Seminar

3rd AI, IP, & Legal Forum

June 6, 2026

Shangai

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

Virtual Seminar

Patent "Basics" Seminar

May 19, 2026

Virtual

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Seminar

IP Strategy at the Crossroads: Technology, Enforcement, and Contracts

May 15, 2026

Taipei

Conference

2026 Advanced Chemical & Biotech Patent Institute

May 11-12, 2026

San Francisco

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP